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In this paper, we formulate a simple latent cure rate model with repair mechanism for a cell exposed
to radiation. This latent approach is a flexible alternative to the models proposed by Klebanov et al.
[A stochastic model of radiation carcinogenesis: latent time distributions and their properties. Math Biosci.
1993;18:51–75], Kim et al. [A new threshold regression model for survival data with a cure fraction.
Lifetime Data Anal. 2011;17:101–122], and is along the lines of the destructive cure rate model formu-
lated recently by Rodrigues et al. [Destructive weighted Poisson cure rate model. Lifetime Data Anal.
2011b;17:333–346]. A new version of the modified Gompertz model and the promotion cure rate model
that takes into account the first passage time of reaching the critical point are discussed, and the estimation
of tumor size at detection is then addressed from the Bayesian viewpoint. In addition, a simulation study
and an application to real data set illustrate the usefulness of the proposed cure rate model.
Keywords: Bayesian paradigm; carcinogenesis; competing causes; cure rate model; first hitting time;
modified Gompertz distribution; probability-generating function; stochastic processes; survival analysis;
weighted Poisson distribution; threshold regression
1. Introduction
Recently, there has been a great interest among statisticians and applied researchers in constructing
flexible cure rate models for better modelling of data with cure proportions (see, for example [1]).
Consequently, a significant progress has been made regarding the generalization of some well-
known cure rate models and their successful application to problems in such wide areas as
engineering, environmetrics, economics and biomedical sciences. In this paper, we focus on
radiation carcinogenesis by taking into account the capacity to repair radiation injury or eliminate
tumour cells after some intensive treatment. Carcinogenesis is believed to involve a two-stage pro-
cess: transformation and growth kinetics. Transformation is the occurrence of changes in a normal
cell generating a malignant or unrepaired cell, while growth kinetics is the process of multiplica-
tion by cell division producing a colony of descendants, called clones. When the random number
of clones reaches a random threshold point, one or more of these clones become a detectable
tumor. Our main goal here is to formulate this expontaneous carcinogenesis process as a latent
cure rate model with repair mechanism and threshold effect. A graphical representation of this
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Figure 1. Two-stage carninogenesis process.
model is presented in Figure 1, where N is the total number of initiated cells, Nt is the total
number of malignant or unrepaired cells and R is the threshold effect. For more details on the
carcinogenesis process from birth–death viewpoint, we refer the readers to [2].
The existing radio-biological evidence on the temporal characteristics of enzymatic repair
mentioned by Klebanov et al. [3] provided the motivation for us to consider the latent cure rate
model for describing the biological process of the elimination of altered cells after a specific
treatment. These authors have provided some specific references on this subject. The latent cure
rate model formulated herein is a simple stochastic model that accommodates repair system
and threshold effect. One of the advantages of this simple model is the nice biological and
competitive interpretation it offers for the behaviour of the neoplastic cells (clonogens) that give
rise to malignant tumor regeneration. In addition, it includes many of the models mentioned by
Kim et al. [4] as special cases.
We formulate the latent cure rate model within a biological context, where the population is
restricted to patients not cured from an event of interest such as disease or tumor. The time to event
(promotion time) for the jth damaged cell (clonogens) is denoted by Xj(j = 1, . . . , N), where N
denotes the unobservable number of damaged cells that can produce the event of interest. In the
sequel, we suppose that N has its probability mass function (pmf) as
pn = P(N = n), n = 0, 1, . . . (1)
Let AN (s) = ∑∞n=0 pnsn (for 0 < s ≤ 1) be the corresponding probability-generating function
(pgf) and p0 the cure rate. We assume that, conditional on N , the Xj’s are i.i.d. random vari-
ables having density function g(x) and survival function S(x) = 1 − G(x). Usually, exponential,
piecewise exponential [5] and Weibull densities are assumed for g(x).
Given N = n and a fixed time t, let Zj (for j = 1, . . . , n) be independent random variables, inde-
pendently of N , following a Bernoulli distribution with success probability p(t) = G(t) indicating
the presence of the jth unrepaired clonogen at time t. The discrete random variable Nt , represent-
ing the total number of unrepaired clonogens among the N initial ones that are still present at time
t, is given by
Nt =
{
Z1 + Z2 + · · · + ZN if N > 0,
0 if N = 0. (2)
In this damaged model, we are assuming that N irradiated cells have the capacity to repair radiation
injury. In other words, we postulate, as in [3], that the initiated cells are subject to repair process
at time t, but the unrepaired cell is promoted with probability one, as done in [6]. It means that
the damaged variable Nt in Equation (2) is the number of activated or unrepaired initiated cells
accumulated up to time t. Klebanov et al. [3] treated the functioning of the repair system as
the M/M/m queue in which p(t) is the probability for the lesion not to be repaired (‘losing a
customer’). Although the process of lesion repair has been disregarded by Yakovlev and Polig [6]
in their model, they did introduce an interesting structure for p(t) by using a property of the
Poisson process. They also used a complex structure for p(t) to allow cell death and for the repair
mechanism, as in [3]. Since the estimation problem is very complicated [6] and not apparent from
the biological point of view, we assume that the probability p(t) of the ith initiated cell to be
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unrepaired or activated by time t is given by p(t) = G(t) and, as in [4], a latent unrepair level R
is associated with the repair mechanism.
It then follows from the fundamental formula for conditional probabilities that
P(Nt = j) =
∞∑
n=j
pn
Binomial(n,G(t))︷ ︸︸ ︷
P(Nt = j | N = n)
and the corresponding pgf [7] is
ANt (s) = AN [1 − (1 − s)G(t)] (3)
for 0 < s ≤ 1. The long-term survival function [8] can be obtained from Equation (3) as
SPop(t) = P(T ≥ t) = ANt (0) = AN [S(t)],
where the lifetime T is linked to the promotion time X and the latent level or critical point R to
be defined in the next section.
The rest of the paper is organized as follows. In Section 2, the latent cure rate model is developed
from the biological viewpoint and a new latent weighted Poisson cure rate model and the modified
Gompertz-G (MG-G) density function are introduced. In Section 3, we offer a new Bayesian
paradigm for the modified Poisson-geometric-G (MPG-G) model. In Section 4, the results of a
simulation study are presented. An example is given in Section 5 which illustrates the usefulness
of the proposed cure rate model. Finally, some concluding remarks are made in Section 6.
2. The latent cure rate model with repair mechanism
We now introduce the basic idea of our latent approach to formulate a simple new cure rate model
under the repair system, or, the stochastic point process {Nt , t > 0} in Equation (2).
Definition 2.1 The lifetime T is under the R-first hitting time (R-FHT) if and only if T = inf{t :
Nt = R ≥ 1} = X(R), for 1 ≤ R ≤ N , where X(1) < X(2) < · · · < X(N) are the order statistics.
The discrete random variable R is called ‘latent level’ of the repair system responsible for the
death of the organism or when the tumor becomes detectable. Thus, R is a critical number of cells
that can be fatal to the patient. The idea of the R-FHT has been studied by Aalen and Gjessing [9]
by considering R as fixed and known. They have suggested that more attention should be paid
to survival models viewed from a process point of view. A discussion of this point of view with
fixed boundary is given by Yakovlev and Tsodikov.[10]
If R = 1, we have the first level of the repair system and R = N the last level one.
Definition 2.2 The R-repair function or the probability to be immune at time t under the R-
activation level is
SR(t) = P(T > t) = P(Nt ≤ R − 1) (4)
for R ≥ 1.
Since T > t is equivalent to Nt < R, the latent cure rate modelling can be useful to formulate
new cure rate models without worrying about any link between the response variable T and
the promotion times Xj or making additional assumptions as in [4]. Also, the derivation of the
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probability distribution of the first passage time to reach the critical point R, or, the ‘critical time’
and the mean of the tumor size or the volume of a tumor at detection can be seen in Chapter
4 of [10]. This is an important modelling problem in the area of spontaneous carcinogenesis.
Here, we present some preliminary results in this direction from the Bayesian viewpoint, but
without involving the first passage time as done in [10]. We also deduce in the appendix many
of the existing cure rate models as special cases of the new latent cure rate model proposed in
Equation (4).
Assuming that Nt is independent of R, the R-repair function at time t is given by
SR(t) = P(T > t) = P(Nt ≤ R − 1) =
∞∑
r=1
P(R = r)
r−1∑
j=0
P(Nt = j)
= E
⎡⎣R−1∑
j=0
P(Nt = j)
⎤⎦ = E
⎡⎣R−1∑
j=0
∞∑
n=j
pn
(
n
j
)
G(t)jS(t)n−j
⎤⎦
. (5)
From Equation (5), the improper density function of T becomes
fR(t) = −E
⎡⎣R−1∑
j=0
dP(Nt = j)
dt
⎤⎦
. (6)
Since the R-repair function in Equation (5) can be expressed as
SR(t) =
∞∑
r=1
P(R = r)
⎡⎣ r−1∑
j=0
pjG(t)j +
r−1∑
j=0
∞∑
n=j+1
pn
(
n
j
)
G(t)jS(t)n−j
⎤⎦
= E
⎡⎣R−1∑
j=0
pjG(t)j
⎤⎦+ E
⎡⎣R−1∑
j=0
∞∑
n=j+1
pn
(
n
j
)
G(t)jS(t)n−j
⎤⎦ , (7)
it is easy to verify that the cure rate is given by
SR(∞) = E
⎛⎝R−1∑
j=0
pj
⎞⎠ = P(N < R).
This is the same cure rate obtained by Kim et al.,[4] but achieved here from a different biological
background. The interpretation of R-repair function in Equation (7) is different from the threshold
cure rate model proposed by Kim et al. [4] encompassing one of the major contribution of the
destructive stochastic process in Equation (2). Also, some special models [4,11] can be obtained
by choosing in Equation (5) some suitable distributions for R.
Now, let us assume that N follows a Poisson distribution with mean θ (see, for example [4]). It
is then known that Nt follows a Poisson distribution with mean θG(t). Thus, using the relationship
between the Poisson and gamma distributions, we can obtain the R-repair and improper density
functions as
SR(t) = E
⎧⎨⎩
R−1∑
j=0
[θG(t)]j e−θG(t)
j!
⎫⎬⎭ = E
[∫ ∞
θG(t)
uR−1 e−u du
(R)
]
(8)
and
fR(t) = θg(t)E
{ [θG(t)]R−1
(R)
e−θG(t)
}
,
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respectively. It is worth mentioning that similar results were obtained by Kim et al. [4] under
the assumption that N and R are independent random variables. Moreover, if R follows a shifted
geometric distribution with parameter ω and pmf
P(R = r) = ω(1 − ω)r−1, r = 1, 2, . . .
for 0 < ω ≤ 1, we obtain the promotion time cure rate model of [4] giving
SR(t) = exp(−θωG(t)) (9)
and
fR(t) = θωg(t) exp(−θωG(t)),
with a cure rate
SR(∞) = P(N < R) = exp(−θωG(t)). (10)
Since the parameter ω characterizes the first passage of the number of unrepaired cells to reach
the critical point R, the model in Equation (9) will be called the ‘modified Poisson-geometric-
G model’ and denoted by MPG-G(ω, θ , G(t | γ)), where G(t | γ) is the cumulative distribution
function (cdf) given an unknown parameter γ . By giving some specific choices for the cdf G(t | γ)
in Equation (9), we can obtain some latent cure rate models of interest as follows:
• Taking γ = ω and G(t | ω) = 1 − e−t/ω, we have the improper modified Gompertz (MG) dis-
tribution used for modelling times to death of patients with pediatric cancer.[12] So, by looking
at this model as a latent cure rate model with threshold and repair mechanism, we now have a
new two-stage biological interpretation for this model.
• If we let ω = 1 in the above shifted geometric distribution and G(t) = 1 − e−t , the MG model
is the simple promotion time model.[13] Gieser et al. [14] extended the MG model, first used
by Cantor and Shuster,[12] by incorporating covariate effects. This extended model provides
a convenient method for the estimation of cure rate as a function of treatments and covariates,
and it will be discussed further in Section 3 from the Bayesian viewpoint.
• Usually, G(t | γ) is taken as a Weibull given γ = (γ1, γ2), where γ1 is the shape parameter and
γ2 the scale parameter. Note that in this particular case the parameter ω is not identifiable as
mentioned by Kim et al.,[4] and so, to solve this problem, we use covariates with intercept as
suggested by Li et al.[15]
• By integrating Equation (9), we obtain the normalization constant of f (t) as
E[e−θωG(T)] = 1 − e
−θω
θω
= 1 − P(N < R)
θω
.
We thus obtain a simple weighted density function as
f (t) = θωg(t)e
−ωG(t)
1 − e−θω , (11)
with the corresponding survival function S(t) as
S(t) = e
−θωG(t) − e−θω
1 − e−θω . (12)
The proper MPG-G(ω, θ , G(t | γ)) density function in Equation (11) will be called ‘MG-G’
density function as a modification of the density introduced by Benjamin Gompertz to graduate
mortality tables and to represent population growth.[16] An extension of this density, called the
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‘generalized Gompertz distribution’, was formulated by Ahuja.[17] It is important to mention
that θω e−θωG(t) in Equation (11) can be seen as a selection mechanism of non-immunes by
assuming that N follows a Poisson distribution with parameter θω under the first activation
mechanism introduced by Rodrigues et al.[18] This is a simple new density function with a
strong biological interpretation, and we hope to study its properties and associated inferential
issues in a future paper. Also, SR(t) in Equation (9) is a standard cure rate model with cure rate
e−θω and the survival function for the non-cured population in Equation (12) is given by
SR(t) = e−θω + (1 − e−θω)S(t). (13)
An interesting application of Equation (13) in a more general framework with random effects
was considered by Li and Ma [19] who also discussed the maximum likelihood estimation
procedures. For more information about the use of Bayesian machinery, we suggest the readers
to see the book by Li and Ma.[20]
We shall now further extend the model in Equation (8) to allow for overdispersion or
underdispersion, as done in Rodrigues et al.[21]
2.1. The likelihood function
Suppose we have n patients in the clinical study. Let ti denote the failure time for the ith patient,
which may be right censored, and νi denote the corresponding censoring indicator which equals
1 if ti is a failure time and 0 if it is right censored. Moreover, let Ni and Ri denote the number
of initiated cells and the antibody level of the repair mechanism for the ith patient, respectively.
Observe that Ni, Nit and Ri are all latent variables. Let D = (n, t, ν) denote the observed data,
where t = (t1, . . . , tn)′ and ν = (ν1, . . . , νn)′. From Equations (5) and (6), under non-informative
censoring, the likelihood function [22] can be expressed as
L(θ , γ | D) =
n∏
i=1
⎧⎨⎩−E
⎡⎣Ri−1∑
j=0
dP(Nit = j | θ , γ )
dt
⎤⎦⎫⎬⎭
νi
⎧⎨⎩E
⎡⎣Ri−1∑
j=0
P(Nit = j | θ , γ )
⎤⎦⎫⎬⎭
1−νi
,
(14)
where
P(Nit = j | θ , γ ) =
∞∑
ni=j
pni(θ)
(
ni
j
)
G(ti | γ )jS(ti | γ )ni−j , i = 1, . . . , n.
3. Bayesian paradigm for the MPG-G model
Following Chen et al.,[13] we formulate a Bayesian procedure by using the MPG-G model with
covariate information. We incorporate covariate information in model (9) thorough a log-linear
link function by taking θi = exp(x′iβ), i = 1, . . . , n, where xi = (xi1, . . . , xip)′ denotes the p × 1
vector of covariates for the ith patient andβ = (β1, . . . , βp)′ is the vector of regression coefficients.
Then, from Equations (9) and (14), the likelihood function becomes
L(β, ω | D) ∝
n∏
i=1
[θiωg(ti | ω)]νi exp[−θiωG(ti | ω)], (15)
where
G(ti | ω) = 1 − exp(−ti/ω), g(ti | ω) = exp(−ti/ω)/ω, (16)
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D = (n, t, ν, X) and X is the n × p matrix of covariates. This model is referred to as the
MG-Gompertz model. We assume that β and ω are a priori independent, π(β) ∝ 1 and the prior
distribution of (β, ω) is given by
π(β, ω | b01, b02) ∝ π(ω | b01, b02) ∝ ωb01−1(1 − ω)b02−1 (17)
for β ∈ Rp and ω ∈ (0, 1), where b01 > 0 and b02 > 0 are two specified hyperparameters. In this
way, the posterior distribution of (β, ω) is given by
π(β, ω | D) ∝ L(β, ω | D)π(ω | b01, b02). (18)
Next, we establish the property of the posterior distribution in Equation (18) under very mild
conditions. It needs to be proved that∫
Rp
∫ 1
0
L(β, ω | D)π(ω | b01, b02) dω dβ < ∞. (19)
Theorem 3.1 Let X∗ be an n × p matrix with rows νix′i. Under the prior distribution in
Equation (17), if X∗ is of full rank, then the posterior distribution in Equation (18) is proper.
The proof of Theorem 3.1 is given in the appendix.
The posterior distribution in Equation (18) does not have a closed-form expression but can be
obtained numerically. This computational problem can be easily handled by using Markov Chain
Monte Carlo (MCMC) methods for sampling from the posterior distribution. From Equations (15–
17), we write the full conditional distributions of β and ω as
π(β | ·) ∝
n∏
i=1
[exp(x′iβ)]νi exp{− exp(x′iβ)ω[1 − exp(−ti/ω)]} (20)
and
π(ω | ·) ∝
n∏
i=1
[exp(−ti/ω)]νi exp{− exp(x′iβ)ω[1 − exp(−ti/ω)]}ωb01−1(1 − ω)b02−1. (21)
It is easy to show that the conditional density functions of β1, . . . , βp in Equation (20) are log-
concave. Thus, we can use the adaptive rejection sampling algorithm [23] to sample from these
distributions. With respect to Equation (21), we have to perform a Metropolis step within the
Gibbs sampler.
Since E(R | ω) = 1/ω, the posterior expectation of the threshold or critical point R is
E(R | D) = E
(
1
ω
∣∣∣∣D) ,
which can be obtained from the marginal posterior distribution of R given by
P(R = r | D) =
∫ ∞
0
P(R = r | ω)π(ω | D) dω. (22)
Also, Yakovlev and Tsodikov [10, Section 4.6] stated that it would be practical and reasonable
to represent the critical point R as R = cV , where V is the volume of a tumor and c is the
concentration of tumor cells per unit of volume. In practice, it is assumed that c = 109 cells/cm3.
So, the posterior distribution of the volume V of a tumor can be obtained from Equation (22) by
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means of the MCMC algorithm, and then the posterior mean of V given by E(V | D) = E(R | D)/c
can be computed. These results would provide an important source of information on the history
of the disease.
As a second model, we take the Weibull distribution in Equation (9) with G(t | γ) = 1 −
exp(−tγ1 eγ2) and g(t | γ) = γ1tγ1−1 exp(γ2 − tγ1 eγ2), for t > 0, γ1 > 0 and γ2 ∈ R. This model
is labelled as the MPG-Weibull model. As in [13], we suppose that β, γ1 and γ2 are a priori
independent. We complete the prior specification with π(β) ∝ 1,
π(γ1) ∝ γ b03−11 exp(−b04γ1) and γ2 ∼ N(b05, b06), (23)
where b03, . . . , b06 are known hyperparameters. With a prior distribution for ω as in Equation (17),
it can be shown that the posterior distribution of (β, γ , ω) is proper under the conditions
stated in [13].
There are various methodologies for comparing models fitted to a data set and for picking the
one that best fits the data. Two of the commonly used criteria are based on the deviance information
criterion (DIC) [24] and the conditional predictive ordinates (CPO).[25] The DIC is built upon
the deviance D(ϑ) = −2 log L(ϑ | D), where ϑ denotes the parameter vector. Using Q samples
ϑ1, . . . ,ϑQ from the Gibbs sampler output, the DIC is computed as DIC = 2D¯(ϑ) −D(ϑ¯), where
D¯(ϑ) = ∑Qq=1D(ϑq)/Q and ϑ¯ = ∑Qq=1 ϑq/Q. Given a set of fitted models, the model yielding
the smallest value of the DIC is the one that best fits the data. For each observation, CPOi can
be approximated as ĈPOi = [{∑Qq=1 1/L(ϑq; Di)}/Q]−1. An omnibus measure of fit based on
the ĈPOi’s is given by the log-pseudo marginal likelihood (LPML) [26] defined as LPML =∑n
i=1 log(ĈPOi). The larger the value of LPML, the better the fit of the model is.
4. Simulation study: MPG-Gompertz model
For evaluating the behaviour of the proposed model in Equation (5), a simulation study was
carried out with G(t | ω) = 1 − exp(−t/ω) and the auxiliary variables xi generated from the
Bernoulli distribution with parameter 0.5. The failure times were simulated from the model in
Equation (9), with ω ∈ {0.1, 0.3, 0.6}, θi = exp(β0 + β1xi), β0 = 2 and β1 = −1. The cure rate
p0i = exp(−ωθi) and the censored times were generated from the uniform distribution, U(0, τ),
where τ controls the censoring mechanism of the uncured patients. We took the proportion of
censored observations to be close to 100(p0i + 0.1)%. The observed times and censoring indicators
were generated through the following steps:
1. Draw ui ∼ U(0, 1);
2. If ui < p0i, set ti = ∞; otherwise, ti = −ω log[1 + log(ui)/(θiω)];
3. Draw ci ∼ U(0, τ);
4. Let wi = min{ti, ci};
5. If ti < ci, set δi = 1; otherwise, δi = 0, i = 1, . . . , n.
The sample sizes were taken as n = 200 and 400. For each simulated data set, the posterior
summaries and 95% high posterior density (HPD) intervals of the model parameters were obtained.
Two parallel chains of size 20,000 were simulated for each parameter, from which the first 5000
iterations were eliminated as burn-in for obtaining a sample of size 15,000. The autocorrelation
of these sampled values were reduced by taking a spacing of size 10 thus resulting in a final
sample of size 1500 for each chain. For each configuration, we conducted 500 replicates and then
determined from the estimates of each parameter the average, the root mean square error (RMSE)
and the coverage probability (CP). These results are all presented in Table 1. We observe that the
RMSE decreases as the sample size increases, and the estimates possess very little bias. We also
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Table 1. Simulation results on the parameters of the MPG-Gompertz model.
Sample size
200 400
ω Parameter Bias SD RMSE CP Bias SD RMSE CP
0.1 β0 −0.035 0.184 0.187 0.940 −0.011 0.128 0.128 0.946
β1 −0.031 0.256 0.258 0.944 −0.023 0.181 0.183 0.948
ω 0.004 0.014 0.014 0.946 0.010 0.009 0.009 0.952
0.3 β0 −0.015 0.123 0.124 0.946 −0.019 0.086 0.088 0.949
β1 −0.020 0.187 0.188 0.928 −0.002 0.123 0.123 0.961
ω 0.15 0.038 0.040 0.962 0.008 0.026 0.028 0.948
0.6 β0 −0.009 0.104 0.104 0.968 −0.003 0.075 0.075 0.948
β1 −0.011 0.168 0.167 0.938 −0.015 0.117 0.118 0.946
ω 0.045 0.096 0.107 0.924 0.023 0.076 0.079 0.942
Note: SD, standard deviation.
observe that the simulated coverage probabilities are quite close to the nominal level especially
when the sample size is 400.
5. The MPG-G models: an illustrative example
Now, we provide an application of the methodology discussed in Section 3 to a real data set. These
data are part of an assay on cutaneous melanoma (a type of malignant cancer) for the evaluation
of postoperative treatment performance with a high dose of a certain drug (interferon alfa-2b) in
order to prevent recurrence. Patients were included in the study from 1991 to 1995, and follow-up
was conducted until 1998. The data were taken from [27] (see also [28]). The data represent the
survival times until the patient’s death or the censoring time. The original sample contains 427
patients, 10 of whom were removed from our analysis, since their tumor thickness data (as a
covariate) are missing. The percentage of censored observations was 56%. The following data
were collected from each subject: observed time (in years); x1: treatment (0: observation, n = 204;
1: interferon, n = 213); x2: age (in years, mean = 48.0 and standard deviation = 13.1); x3: nodule
category (1, n = 82; 2, n = 87; 3, n = 137; 4, n = 111); x4: sex (0: male, n = 263; 1: female,
n = 154); x5: performance status (PS) means patient’s functional capacity scale as regards his or
her daily activities (0: fully active, n = 363; 1: other, n = 54) and x6: tumor thickness (in mm,
mean = 3.94 and standard deviation = 3.20).
The prior distribution for ω in Equation (17) is chosen as uniform on (0, 1). The MPG-Gompertz
and MPG-Weibull models presented in Section 3 were fitted to these data. For each model,
we generate two parallel independent runs of the Gibbs sampler with size 150,000 for each
parameter, disregarding the first 50,000 iterations as burn-in to eliminate the effect of the ini-
tial values and, to reduce the autocorrelation in the sampled values, we then took a spacing
of size 20, obtaining 5000 samples from each chain. The hyperparameters for the distribu-
tions in Equation (23) were chosen as b03 = 1, b04 = 1, b05 = 0 and b06 = 100 in order to
obtain proper non-informative priors. MCMC computations were implemented in OpenBUGS
version 3.2.1.[29] The codes are available from the corresponding author. To monitor the con-
vergence of the Gibbs sampler, we used the method of Gelman and Rubin.[30] The potential
scale reduction factors range from 1.000 to 1.009 indicating the convergence of the chains. For
the MPG-Gompertz model, we obtain (DIC, LPML) = (1038, −519.7622), whereas the results
for the MPG-Weibull and the promotion-Weibull models are (DIC, LPML) = (1029, −520) and
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Table 2. Posterior summaries on the parameters of the MPG-Weibull model.
Parameter Mean Standard deviation 95% HPD interval
βtreatment 0.069 0.151 (−0.222, 0.365)
βage 0.009 0.006 (−0.003, 0.012)
βnodule 0.370 0.069 (0.231, 0.504)
βsex −0.186 0.155 (−0.490, 0.112)
βPS 0.137 0.217 (−0.300, 0.546)
βthickness 0.018 0.022 (−0.025, 0.060)
γ1 1.726 0.116 (1.496 1.955)
γ2 −1.665 0.137 (−1.936, −1.406)
ω 0.192 0.078 (0.081, 0.382)
(DIC, LPML) = (1034, −517.3295), respectively. Hence, the MPG-Weibull model provides a
much better fit than the MPG-Gompertz model, and a possible biological reason is the restriction
0 < ω ≤ 1, where ω is the mean of the exponential Gompertz distribution. For the MPG-Weibull
model, we take log(ω) as the intercept parameter in order to avoid identifiability problems.[15]
Hereafter, we report the results only for the MPG-Weibull model.
In Table 2, we present the posterior summaries for the parameters of the MPG-Weibull model.
From Table 2, we conclude from the 95% HPD intervals that all regression coefficients except for
nodule category are non-significant. Since βˆnodule > 0, we also note that the greater the nodule
category, the smaller the cure rate is (Equation (10)).
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Figure 2. Sequence plots of the chains – MPG-Weibull model.
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Table 3. Posterior summaries of the parameters and cure rates for
the reduced MPG-Weibull models.
Parameter Standard 95%
and cure rate Mean deviation HPD interval
βnodule 0.360 0.069 (0.223, 0.495)
γ1 1.720 0.116 (1.492, 1.944)
γ2 −1.649 0.136 (−1.923, −1.393)
ω 0.296 0.060 (0.194, 0.428)
p0(1) 0.659 0.039 (0.579, 0.732)
p0(2) 0.552 0.033 (0.485, 0.612)
p0(3) 0.427 0.034 (0.359, 0.492)
p0(4) 0.297 0.047 (0.208, 0.392)
Next, as a reduced model, we fit a model including only the nodule category (x3) as
covariate and log(ω) as an intercept parameter. From Equation (10), the cure rate is given
by p0(x3) = ω exp[−(βnodulex3)] = exp[− exp(log(ω) + βnodulex3)], where x3 ∈ {1, 2, 3, 4}. The
sequence plots in Figure 2 reveal a good mixing of the chains. Plots were drawn in the R system.[31]
The posterior summaries displayed in Table 3 and Figure 3 allow us to assess the effect of the
nodule category on the cure rate. The variability in the estimates is larger for the lowest and the
highest categories. The 95% HPD interval for p0(4) overlaps only with the interval for p0(3),
while the HPD intervals for p0(3) and p0(1) do not overlap. Furthermore, the posterior summaries
for γ1 provide evidence against the exponential distribution (γ1 = 1). Finally, Figure 4 suggests
the data’s support for the first activation scheme or promotion time cure rate model (R = 1). On
the other hand, the posterior mean of ω and its 95% HPD interval indicates a smaller cure rate for
different nodule category x3 than the usual promotion model with ω = 1 and they are similar to
the results obtained by Rodrigues et al. [32] by using the COM-Poisson cure rate model. In other
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Figure 3. Posterior density estimates for the cure rates corresponding to different nodule categories – reduced
MPG-Weibull model.
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Figure 4. Marginal posterior distribution of R for the reduced MPG-Weibull model.
words, this latent reduced model takes into account the uncertainty in the first activation scheme
without conditioning on Nt as in the hierarchical-activation proposed by Cooner et al. [11] and a
very simple alternative to the COM-Poisson cure rate model.
6. Concluding remarks
Zelen [33] stated that a key assumption in making the latent cure rate model best fitted to a given
data is that the threshold or the critical number of unrepaired cells be treated as stochastic while
it is not that important whether the growth is assumed to be stochastic or not. This statement
motivated us to consider the cure rate model under the random activation and repair schemes,
which is close to the main ideas present in the works of Cooner et al. [11] and Kim et al.[4] Those
interested in modelling tumor recurrence may consult Chapter 4 of [10] for many related ideas
in this regard. An important problem in application is to obtain the probability distribution of the
time for unrepaired initiated cells to increase in number up to the value of R. This random time
variable is known as the first passage time, or the time of tumor detection, as detailed in [10].
Under the proposed latent cure model, it is possible to give a biological interpretation for the MG
model to survival times. Another problem of interest is to derive the distribution of tumor size at
detection (see Chapter 4 of [10]) which would provide valuable information on the history of the
disease. Work on some of these issues is currently under progress and we hope to report these
findings in a future paper. The MPG-Weibull models discussed in Section 5 are alternatives to the
hierarchical-activation schemes formulated by Cooner et al. [11] and the cure fraction proposed
by Kim et al. [4], in the sense that the cure rate is adjusted by our uncertainty on the latent
random threshold variable with biological interpretation. Furthermore, the stochastic process
{Nt , t > 0} is the key idea of the latent approach formulated here which is a model innovation
and an important major difference from the previous works of Kim et al. [4] and Rodrigues
et al.[21] Also, it is worth mentioning that it has a potential use to analyse high dimensional data
such as genetic data in survival analysis (see, for example, the Chapter 6 of the book by Li and
Ma [20]) and also in some other applied fields such as econometrics, sociology, engineering and
reliability.
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Appendix. Proof of Theorem 3.1
As in [13], in order to prove Theorem 3.1, we begin by showing that there exists a constant M < 1 such that
{θiωg(ti | ω)}νi exp[−θiωG(ti | ω)] ≤ M. (A.1)
Since exp[−θiωG(ti | ω)] ≤ 1, when νi = 0, Equation (A.1) is immediate. For νi = 1, by Equation (16), the left-hand
side of Equation (A.1) can be rewritten as
t−1i
ti exp(−ti/ω)/ω
1 − exp(−ti/ω) θiωG(ti | ω) exp[−θiωG(ti | ω)]. (A.2)
Defining
h1(z) = z e
−z
1 − e−z and h2(z) = z e
−z for z > 0,
it can be shown that there exists a common constant h0 > 0 satisfying
h1(z) ≤ h0 and h2(z) ≤ h0 for all z > 0. (A.3)
By using Equation (A.3) in Equation (A.2), we have
t−1i
ti exp(−ti/ω)/ω
1 − exp(−ti/ω) θiωG(ti | ω) exp[−θiωG(ti | ω)] ≤ t
−1
i h
2
0.
Thus, taking M∗ = h20 maxi:νi=1(t−1i ) and M = max(1, M∗), we obtain Equation (A.1).
Since X∗ has full rank, we can assert the existence of p linearly independent vectors x′i1 , x
′
i2 , . . . , x
′
ip such that δi1 =
δi2 = · · · = δip = 1. From Equations (15) and (A.1), we have∫
Rp
∫ 1
0
L(β, ω | D)π(ω | b01, b02) dω dβ
≤
∫
Rp
∫ 1
0
Mp
p∏
j=1
exp(x′ijβ)ωg(tij | ω) exp[− exp(x′ijβ)ωG(tij | ω)]
× π(ω | b01, b02) dω dβ. (A.4)
For simplification, we take the one-to-one linear transformation uj = x′ijβ, j = 1, . . . , p, from β to u = (u1, . . . , up)′. In
this way, Equation (A.4) becomes proportional to∫ 1
0
∫
Rp
exp(uj)ωg(tij | ω) exp[− exp(uj)ωG(tij | ω)]π(ω | b01, b02) du dω
=
∫ 1
0
wp
p∏
j=1
{
g(tij | ω)
∫ ∞
−∞
exp[uj − ω exp(uj)G(tij | ω)] duj
}
π(ω | b01, b02) dω. (A.5)
Integrating over u in Equation (A.5), we obtain∫ 1
0
ωp
p∏
j=1
g(tij | ω)
ωG(tij | ω)
π(ω | b01, b02) dω. (A.6)
Upon using Equations (A.6) and (16) in Equation (A.3), we obtain
g(tij | ω)
G(tij | ω)
= t−1i
ti exp(−ti/ω)/ω
1 − exp(−ti/ω) ≤ M0,
where M0 = h0 max1≤j≤p(t−1ij ). Now, upon taking Equation (17) into account, we have the expression in Equation (A.6)
to be less than or equal to
Mp0
∫ 1
0
π(ω | b01, b02) dω < ∞.
Thus, Equation (19) is satisfied, which completes the proof of the theorem.
